Influenza
AstraZeneca’s nasal flu vaccine nears FDA approval
Anika Sharma
AstraZeneca’s FluMist, a nasal spray flu vaccine with a two-decade history, is poised to potentially become available for self-administration as ...
Pneumagen’s nasal spray shows promise in preventing and treating flu infections, phase 2 trial reveals
Anika Sharma
Pneumagen, the Scottish pharmaceutical company, has achieved a significant breakthrough in the fight against influenza through an unconventional approach to ...
Janssen Drops Cidara’s Flu Medicine After Disappointing Phase 2 Results
Anika Sharma
Janssen is honoring its 2021 agreement with Cidara Therapeutics regarding the development of CD388, a flu prophylaxis treatment. However, Janssen ...
The pipeline for RSV, influenza, meningitis, and pneumococcal disease vaccines raises the bar
SG Tylor
Source – Sanofi On June 29, 2023, Sanofi is hosting an investor event focused on its Vaccines pipeline, featuring key ...
